Similar articles for PMID: 27512768

Year	Number of Results
1999	1
2001	1
2002	1
2003	1
2004	4
2005	4
2006	3
2007	3
2008	3
2009	3
2010	1
2011	4
2012	1
2013	5
2014	7
2015	7
2016	4
2017	2
2018	2
2019	2
2020	1
2021	1
2022	2
2023	2
2024	0

1

Gene Expression in Wilms Tumor: Disturbance of the Wnt Signaling Pathway and MicroRNA Biogenesis.

Carraro DM, Ramalho RF, Maschietto M. Carraro DM, et al. In: van den Heuvel-Eibrink MM, editor. Wilms Tumor [Internet]. Brisbane (AU): Codon Publications; 2016 Mar. Chapter 10. In: van den Heuvel-Eibrink MM, editor. Wilms Tumor [Internet]. Brisbane (AU): Codon Publications; 2016 Mar. Chapter 10. PMID: 27512768 Free Books & Documents. Review.

2

Myogenesis in Wilms' tumors is associated with mutations of the WT1 gene and activation of Bcl-2 and the Wnt signaling pathway.

Fukuzawa R, Heathcott RW, Sano M, Morison IM, Yun K, Reeve AE. Fukuzawa R, et al. Pediatr Dev Pathol. 2004 Mar-Apr;7(2):125-37. doi: 10.1007/s10024-003-3023-8. Epub 2004 Mar 4. Pediatr Dev Pathol. 2004. PMID: 14994125

3

Temporal blastemal cell gene expression analysis in the kidney reveals new Wnt and related signaling pathway genes to be essential for Wilms' tumor onset.

Maschietto M, Trapé AP, Piccoli FS, Ricca TI, Dias AA, Coudry RA, Galante PA, Torres C, Fahhan L, Lourenço S, Grundy PE, de Camargo B, de Souza S, Neves EJ, Soares FA, Brentani H, Carraro DM. Maschietto M, et al. Cell Death Dis. 2011 Nov 3;2(11):e224. doi: 10.1038/cddis.2011.105. Cell Death Dis. 2011. PMID: 22048167 Free PMC article.

4

Canonical WNT signalling determines lineage specificity in Wilms tumour.

Fukuzawa R, Anaka MR, Weeks RJ, Morison IM, Reeve AE. Fukuzawa R, et al. Oncogene. 2009 Feb 26;28(8):1063-75. doi: 10.1038/onc.2008.455. Epub 2009 Jan 12. Oncogene. 2009. PMID: 19137020

5

Nuclear accumulation of beta-catenin protein in Wilms' tumours.

Koesters R, Niggli F, von Knebel Doeberitz M, Stallmach T. Koesters R, et al. J Pathol. 2003 Jan;199(1):68-76. doi: 10.1002/path.1248. J Pathol. 2003. PMID: 12474228

6

WNT/beta-catenin pathway activation in Wilms tumors: a unifying mechanism with multiple entries?

Corbin M, de Reyniès A, Rickman DS, Berrebi D, Boccon-Gibod L, Cohen-Gogo S, Fabre M, Jaubert F, Faussillon M, Yilmaz F, Sarnacki S, Landman-Parker J, Patte C, Schleiermacher G, Antignac C, Jeanpierre C. Corbin M, et al. Genes Chromosomes Cancer. 2009 Sep;48(9):816-27. doi: 10.1002/gcc.20686. Genes Chromosomes Cancer. 2009. PMID: 19530245

7

Mutational activation of the beta-catenin proto-oncogene is a common event in the development of Wilms' tumors.

Koesters R, Ridder R, Kopp-Schneider A, Betts D, Adams V, Niggli F, Briner J, von Knebel Doeberitz M. Koesters R, et al. Cancer Res. 1999 Aug 15;59(16):3880-2. Cancer Res. 1999. PMID: 10463574

8

Target genes of the WNT/beta-catenin pathway in Wilms tumors.

Zirn B, Samans B, Wittmann S, Pietsch T, Leuschner I, Graf N, Gessler M. Zirn B, et al. Genes Chromosomes Cancer. 2006 Jun;45(6):565-74. doi: 10.1002/gcc.20319. Genes Chromosomes Cancer. 2006. PMID: 16575872

9

Chibby, a novel antagonist of the Wnt pathway, is not involved in Wilms tumor development.

Zirn B, Wittmann S, Graf N, Gessler M. Zirn B, et al. Cancer Lett. 2005 Mar 18;220(1):115-20. doi: 10.1016/j.canlet.2004.08.001. Cancer Lett. 2005. PMID: 15737694

10

Wilms tumor cells with WT1 mutations have characteristic features of mesenchymal stem cells and express molecular markers of paraxial mesoderm.

Royer-Pokora B, Busch M, Beier M, Duhme C, de Torres C, Mora J, Brandt A, Royer HD. Royer-Pokora B, et al. Hum Mol Genet. 2010 May 1;19(9):1651-68. doi: 10.1093/hmg/ddq042. Epub 2010 Jan 27. Hum Mol Genet. 2010. PMID: 20106868

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

60 results

Results by year